MedTrace Logo

Pneumococcal Vaccination in Patients with Anti-TNF Alpha Therapy

NCT05788510 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 106

Last updated 2024-09-19

No results posted yet for this study

Summary

As the vaccination of immunosuppressed people is insufficiently performed in France, it seems interesting to carry out an evaluation of the situation on the site of the NOVO - Pontoise hospital.

The aim of this study is to assess the status of pneumococcal vaccination in patients at the NOVO hospital - Pontoise site, who have received anti-TNF alpha therapy.

Conditions

  • Pneumococcal Vaccine

Interventions

OTHER

Pneumococcal vaccine

Investigation of vaccination status, for Pneumococcal vaccine , of patients who received anti-TNF alpha therapy

Sponsors & Collaborators

  • Hôpital NOVO

    lead OTHER

Principal Investigators

  • Dr Christine Trumtel · NOVO Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-04-03
Primary Completion
2023-05-06
Completion
2023-05-06

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05788510 on ClinicalTrials.gov